Intuitive Machines stock climbs on lunar mission plan as McDonald's edges higher ahead of results
By MarketWatch
Here are the biggest movers of the day:
Stock gainers:
Coherus BioSciences stock (CHRS) rose 17% as the Food and Drug Administration approved its treatment for nasopharyngeal cancer when combined with chemotherapy that it makes with Shanghai Junshi Biosciences.
Intuitive Machines shares (LUNR) rose 13% as it scheduled its lunar lander mission with SpaceX for January, a delay of two months.
McDonald's (MCD) shares rose 1% ahead of results from the fast-food chain operator.
Stock decliners:
ArcelorMittal shares (MT) fell 4%. The steelmaker said it signed an agreement to transfer its Kazakhstan operations to the government before a fatal incident at a coal mine this weekend.
-MarketWatch
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-30-23 0520ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
The Best REITs to Buy
-
3 Hot Stocks to Buy That Still Look Undervalued
-
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
Today’s Market Volatility Could Provide Tomorrow’s Opportunities
-
40 of the Best Investment Picks
-
Tech Stock Dividends Are Changing the Face of Dividend Growth Investing
-
Roblox Earnings: Weakening Engagement Has Weighed On Growth
-
The Best Gaming Stocks to Buy